Viewing StudyNCT03256136



Ignite Creation Date: 2024-05-06 @ 10:26 AM
Last Modification Date: 2024-10-26 @ 12:30 PM
Study NCT ID: NCT03256136
Status: COMPLETED
Last Update Posted: 2020-11-04
First Post: 2017-08-17

Brief Title: Nivolumab in Combination With Chemotherapy or Nivolumab in Combination With Ipilimumab in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
Lung Cancer View